215 related articles for article (PubMed ID: 18326619)
1. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study.
Depeint F; Tzortzis G; Vulevic J; I'anson K; Gibson GR
Am J Clin Nutr; 2008 Mar; 87(3):785-91. PubMed ID: 18326619
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain, Bifidobacterium bifidum NCIMB 41171.
Tzortzis G; Goulas AK; Gibson GR
Appl Microbiol Biotechnol; 2005 Aug; 68(3):412-6. PubMed ID: 15703907
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers.
Vulevic J; Drakoularakou A; Yaqoob P; Tzortzis G; Gibson GR
Am J Clin Nutr; 2008 Nov; 88(5):1438-46. PubMed ID: 18996881
[TBL] [Abstract][Full Text] [Related]
4. BbgIV Is an Important Bifidobacterium β-Galactosidase for the Synthesis of Prebiotic Galactooligosaccharides at High Temperatures.
Osman A; Tzortzis G; Rastall RA; Charalampopoulos D
J Agric Food Chem; 2012 Jan; 60(3):740-8. PubMed ID: 22148735
[TBL] [Abstract][Full Text] [Related]
5. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
Bouhnik Y; Raskine L; Simoneau G; Vicaut E; Neut C; Flourié B; Brouns F; Bornet FR
Am J Clin Nutr; 2004 Dec; 80(6):1658-64. PubMed ID: 15585783
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans.
Kolida S; Meyer D; Gibson GR
Eur J Clin Nutr; 2007 Oct; 61(10):1189-95. PubMed ID: 17268410
[TBL] [Abstract][Full Text] [Related]
7. A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo.
Tzortzis G; Goulas AK; Gee JM; Gibson GR
J Nutr; 2005 Jul; 135(7):1726-31. PubMed ID: 15987856
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species.
Rabiu BA; Jay AJ; Gibson GR; Rastall RA
Appl Environ Microbiol; 2001 Jun; 67(6):2526-30. PubMed ID: 11375159
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of β-Galactooligosaccharide Using Bifidobacterial β-Galactosidase Purified from Recombinant
Oh SY; Youn SY; Park MS; Kim HG; Baek NI; Li Z; Ji GE
J Microbiol Biotechnol; 2017 Aug; 27(8):1392-1400. PubMed ID: 28535609
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
Silk DB; Davis A; Vulevic J; Tzortzis G; Gibson GR
Aliment Pharmacol Ther; 2009 Mar; 29(5):508-18. PubMed ID: 19053980
[TBL] [Abstract][Full Text] [Related]
11. Prebiotic Galactooligosaccharide Metabolism by Probiotic Lactobacilli and Bifidobacteria.
Thongaram T; Hoeflinger JL; Chow J; Miller MJ
J Agric Food Chem; 2017 May; 65(20):4184-4192. PubMed ID: 28466641
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
[TBL] [Abstract][Full Text] [Related]
13. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides--a human volunteer study.
Tuohy KM; Kolida S; Lustenberger AM; Gibson GR
Br J Nutr; 2001 Sep; 86(3):341-8. PubMed ID: 11570986
[TBL] [Abstract][Full Text] [Related]
14. Diverse galactooligosaccharides consumption by bifidobacteria: implications of β-galactosidase--LacS operon.
Akiyama T; Kimura K; Hatano H
Biosci Biotechnol Biochem; 2015; 79(4):664-72. PubMed ID: 25483279
[TBL] [Abstract][Full Text] [Related]
15. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates.
Garrido D; Ruiz-Moyano S; Jimenez-Espinoza R; Eom HJ; Block DE; Mills DA
Food Microbiol; 2013 Apr; 33(2):262-70. PubMed ID: 23200660
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of β-galactosidase from probiotic Pediococcus acidilactici and its use in milk lactose hydrolysis and galactooligosaccharide synthesis.
Chanalia P; Gandhi D; Attri P; Dhanda S
Bioorg Chem; 2018 Apr; 77():176-189. PubMed ID: 29421696
[TBL] [Abstract][Full Text] [Related]
18. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Bartosch S; Woodmansey EJ; Paterson JC; McMurdo ME; Macfarlane GT
Clin Infect Dis; 2005 Jan; 40(1):28-37. PubMed ID: 15614689
[TBL] [Abstract][Full Text] [Related]
19. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
[TBL] [Abstract][Full Text] [Related]
20. Production of galactooligosaccharides using various combinations of the commercial β-galactosidases.
Botvynko A; Bednářová A; Henke S; Shakhno N; Čurda L
Biochem Biophys Res Commun; 2019 Oct; 517(4):762-766. PubMed ID: 31395344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
